ATOSSA THERAPEUTICS, INC. — Director's Dealing 2013

Nov 22, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2013-11-21

Reporting Person: WEAVER GREGORY L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-21	Common Stock	P	10000	$2.5785	Acquired	34510	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.5671 to $2.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2: Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person which are subject to certain vesting conditions.